The online version of this article (https://doi.org/10.1007/s11255-017-1766-9) contains supplementary material, which is available to authorized users.
To describe the patient characteristics, treatments, disease monitoring, and kidney function of patients with sporadic angiomyolipoma (sAML), stratified by the number and size of renal angiomyolipomas (AMLs).
Single-center retrospective analysis of patients with sAML treated from 1990 to 2015 in a dedicated clinic for inheritable tumor syndromes in a tertiary referral center from the Netherlands. Patients’ first AML assessment at the clinic was defined as the index date. Patient characteristics were measured at the index date. Treatments, disease monitoring, and kidney function were measured post-index date.
The study sample included 53 patients followed for a total of 184.6 patient-years. At the index date, the largest AML was ≥ 3.5 cm for 26 patients and < 3.5 cm for 27 patients (including six patients with five or more AMLs of < 3.5 cm). As compared to patients with AMLs < 3.5 cm, patients with largest AML ≥ 3.5 cm had higher frequency of pre-index bleeding episodes (31 vs. 4%), pre-index hypertension (35 vs. 15%), post-index nephrectomy (19 vs. 4%), post-index embolization (8 vs. 0%), and post-index renal scans (1.14 vs. 0.74 scans/year). Kidney impairment was especially pronounced in young adults with AML ≥ 3.5 cm. On average, patients with sAML developed chronic kidney disease stage two earlier than the general Dutch population (age 42 vs. 55 years), but later than the patients with tuberous sclerosis complex (35 years).
Patients with sAML, especially those with larger AMLs, have high disease burden.
eFig. 1 Change of eGFR over time among patients in the sAML study sample for whom there was sufficient eGFR information (N=6) (DOCX 50 kb)11255_2017_1766_MOESM1_ESM.docx
Skolarus TA, Serrano MF, Berger DA et al (2008) The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol 179(2):439–443. https://doi.org/10.1016/j.juro.2007.09.076 (discussion 443–4) CrossRefPubMed
Nelson CP, Sanda MG (2002) Contemporary diagnosis and management of renal angiomyolipoma. J Urol 168(4 Pt 1):1315–1325. https://doi.org/10.1097/01.ju.0000028200.86216.b2 CrossRefPubMed
Seyam RM, Bissada NK, Kattan SA et al (2008) Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology 72(5):1077–1082. https://doi.org/10.1016/j.urology.2008.07.049 CrossRefPubMed
Sooriakumaran P, Gibbs P, Coughlin G et al (2010) Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 105(1):101–106. https://doi.org/10.1111/j.1464-410X.2009.08649.x CrossRefPubMed
Bhatt JR, Richard PO, Kim NS et al (2016) Natural history of renal angiomyolipoma (AML): most patients with large AMLs > 4 cm can be offered active surveillance as an initial management strategy. Eur Urol 70(1):85–90. https://doi.org/10.1016/j.eururo.2016.01.048 CrossRefPubMed
Albi G, del Campo L, Tagarro D (2002) Wünderlich’s syndrome: causes, diagnosis and radiological management. Clin Radiol 57(9):840–845. https://doi.org/10.1016/S0899-7071(03)00058-5 CrossRefPubMed
Zhang JQ, Fielding JR, Zou KH (2002) Etiology of spontaneous perirenal hemorrhage: a meta-analysis. J Urol 167(4):1593–1596. https://doi.org/10.1016/S0022-5347(05)65160-9 CrossRefPubMed
Ljungberg B, Bensalah K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005 CrossRefPubMed
Bissler JJ, Kingswood JC (2004) Renal angiomyolipomata. Kidney Int 66(3):924–934. https://doi.org/10.1111/j.1523-1755.2004.00838.x CrossRefPubMed
Eijkemans MJC, van der Wal W, Reijnders LJ et al (2015) Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am J Kidney Dis 66(4):638–645. https://doi.org/10.1053/j.ajkd.2015.05.016 CrossRefPubMed
Vekeman F, Magestro M, Karner P et al (2015) Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ 18(12):1060–1070. https://doi.org/10.3111/13696998.2015.1075995 CrossRefPubMed
Eckardt K-U, Berns JS, Rocco MV, Kasiske BL (2009) Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO. Am J Kidney Dis 53(6):915–920. https://doi.org/10.1053/j.ajkd.2009.04.001 CrossRefPubMed
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006 CrossRefPubMedPubMedCentral
Boorjian SA, Frank I, Inman B et al (2007) The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology 70(6):1064–1068. https://doi.org/10.1016/j.urology.2007.07.045 CrossRefPubMed
Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD (2010) Trends of presentation and clinical outcome of treated renal angiomyolipoma. Yonsei Med J 51(5):728–734. https://doi.org/10.3349/ymj.2010.51.5.728 CrossRefPubMedPubMedCentral
Maclean DFW, Sultana R, Radwan R, McKnight L, Khastgir J (2014) Is the follow-up of small renal angiomyolipomas a necessary precaution? Clin Radiol 69(8):822–826. https://doi.org/10.1016/j.crad.2014.03.016 CrossRefPubMed
- Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center
J. L. H. Ruud Bosch
Mei Sheng Duh
Bernard A. Zonnenberg
- Springer Netherlands
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II